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adjuvants for vaccines. We have simulated the adsorption of GnRH-I (gonadotrophin releasing hormone I) 
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the widely-used carrier protein bovine serum albumin (BSA). Our subsequent immunological studies 
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orientation of the peptides at the silica surface found in the simulations. With the BSA systems, we found 
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with the epitope presentation predicted by the simulations. The range of immunological and hormone 
response can therefore be interpreted and understood by the simulation results and the presentation 
of the peptides to solution, paving the way for the future rational design of drug delivery and vaccine 
systems guided by biomolecular simulation.
he use of nanoparticles, and silica nanoparticles (SiNPs) in particular, as efective drug delivery vehicles has been 
the topic of much recent research1–4. Silica has excellent biodegradable properties and is generally recognised as 
safe for use in cosmetics and food additives, and SiNPs ofer control of drug loading and release5. SiNPs have also 
been used for antigen carriers and adjuvants for vaccine delivery3. Since there is a reported decline in the devel-
opment of new efective vaccines against a number of major diseases as well as novel targets such as cancer6, it 
is imperative that we obtain a better understanding of how the drug delivery systems work and therefore how to 
design new and efective vaccine systems with improved antigen presentation7.
In this study we used SiNPs loaded with the model peptide gonadotrophin releasing hormone I (GnRH-I) and 
a cysteine-tagged modiied peptide (cys-GnRH-I), an established antigen developed for contraceptive use8. In 
order to gain new understanding into how this model system behaves at the molecular level, we performed fully 
atomistic biomolecular simulations of the peptide interactions with a model silica surface. We then performed 
immunisation studies, and aim to interpret the results of these using the structural details provided by the sim-
ulation. In this way, we hope to demonstrate not only the power of simulation to provide new understanding for 
the interpretation of experimental results, but also its potential to guide the future formulation of efective drug 
delivery and adjuvant systems. he modelling work is not restricted to SiNPs, and indeed it shows that other 
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materials with similar physico-chemical properties could be used. he advantages of such an in silico design strat-
egy include economic savings of labour and materials; the ethical reduction in animal studies; and most crucially 
a molecular-scale insight into key processes that is not achievable in any other way.
GnRH-I is a decapeptide that is produced by the hypothalamus and stimulates the release of follicle-stimulating 
hormone (FSH) and luteinising hormone (LH) in females and males. As such, GnRH-I efectively regulates fer-
tility9, and immunisation against GnRH-I can have a major efect on the fertility of both sexes in mammals10–15. 
his is caused by antibodies, induced by the vaccine, neutralising any circulating GnRH-I, thus preventing it from 
stimulating FSH and LH secretion8. However, since GnRH-I is a naturally occurring self-peptide, it needs to be 
conjugated to a foreign carrier protein to induce the required immune response13. Indeed, with peptide vaccines 
an adjuvant is very oten crucial to stimulate the immune response to adequate levels.
We used 200 nm Stöber SiNPs as the adjuvant, since these have proven their eicacy in other vaccine stud-
ies1,2,16–19. he interaction of proteins and peptides with inorganic materials has been studied using fully atomistic 
molecular dynamics (MD) simulations by a number of groups20–28. For example, model silica surfaces have been 
used to understand and interpret experimental lysozyme adsorption23, as well as the functionalisation of SiNPs 
with cell penetrating peptides22. In this work we used our simulation approach29 to investigate how the GnRH-I 
and cys-GnRH-I peptides interact with the model silica surface. We also simulated the behaviour of cys-GnRH-I 
covalently bonded to the surface of the carrier protein bovine serum albumin (BSA). With these simulations, we 
obtained novel insight into the morphological arrangements of the peptides at the adjuvant surfaces, and how key 
epitopes are presented to the biological environment.
In our experiments, we explored the efect of Stöber SiNPs and BSA, both separately and combined, as immu-
nopotentiators in combination with GnRH-I and cys-GnRH-I. he BSA and SiNPs both acted as foreign mole-
cules to trigger the immune system into a response. he efectiveness of the response was assessed and compared 
by measuring the GnRH-speciic antibody and testosterone levels in male mice that received the diferent vacci-
nation formulations subcutaneously over a period of 13 weeks. We also investigated the impact of the treatments 
on spermatogenesis. We found that the various treatments induced diferent responses, and importantly, we were 
able to interpret and understand the results with reference to the simulation studies. We believe that this paves the 
way for new possibilities using simulation tools to design new vaccine formulations and thereby greatly reduce 
the cost and time of the experimental phase of vaccine development.
Results
Molecular Dynamics Simulations (MD): single peptides in bulk solution. he GnRH-I and cys-
GnRH-I structures in bulk solution, without any surface interaction, are illustrated in Fig. 1. he peptides tend 
to adopt hairpin bend conformations as shown. Figure 1 also shows the charged residues in the structures. he 
native GnRH-I comprises a negative glutamic acid (Glu1) residue at the positive N-terminus, a positive arginine 
(Arg8) and the negative C-terminus, and so has no overall charge at pH 7. In contrast, the cys-GnRH-I has the 
Glu1 replaced by a neutral cysteine residue. his does not dramatically impact the peptide conformation in bulk 
solution, but it leads to a change in the overall charge and its distribution along the chain. his will impact how it 
adsorbs to the silica surface as explained below.
MD: Single Peptide Adsorption to the Silica Surface. We performed a number of independent simu-
lations for single GnRH-I and cys-GnRH-I adsorbing to the model silica surface. While the simulations difer in 
details such as the time it takes for the adsorption to occur, they all follow the same pathway to adsorption and 
have the same peptide-dependent adsorbed conformation that we now describe.
Although the native GnRH-I is neutral, it has a dipole moment running from the charged Arg8 to the nega-
tively charged C-terminus (Fig. 1). herefore, in the adsorption simulations, GnRH-I oriented in the electric ield 
above the siloxide-terminated surface prior to adsorption. Since the surface ield was screened by the counter ions 
in solution, the adsorption was relatively slow, occurring on a 10 ns timescale in the simulations. his allowed the 
peptide time to difuse above the surface and ind its preferred orientation before adsorption, a process described 
elsewhere22,29. When the peptide adsorbed, it was steered by Arg8, whose positive side-chain extended towards 
the negatively charged surface. his steering process enabled the side-chain to penetrate the water layers that 
formed at the surface, leading to strong adsorption and anchoring at the surface. he crucial role played by Arg 
in protein adsorption at negatively charged surfaces has been described elsewhere23,25,30–32. Subsequently, the 
rest of the peptide tended to collapse to the surface bound by numerous short-range van der Waals forces, which 
are weaker than electrostatic forces yet suicient in number to bind the peptide to the surface. herefore, the 
inal adsorbed conformation was such that GnRH-I was strongly anchored in its centre by Arg8, but its negative 
C-terminus was only loosely bound to the surface and so more available for interactions with the solvent environ-
ment. he N-terminus is neutral, and so was also loosely bound to the silica surface.
A typical adsorption conformation is shown in Fig. 2. We note that due to the luctuating environment, the 
conformation could evolve, but the peptide remained bound to the surface with very little centre-of-mass difu-
sion across the surface apparent in our 50 ns trajectories (data not shown).
In contrast, the cys-GNRH-I peptide has a net positive charge with a dipole moment running from the neg-
ative C-terminus to the positive N-terminus (Fig. 1). When this peptide aligned in the electric ield above the 
surface it was elongated normal to the surface. Again this peptide had time to difuse above the surface before 
adsorbing due to the screening efect of the counter ions in solution. Indeed, the cys-GnRH-I initially adsorbed in 
this conformation, with the positively charged N-terminus acting as an initial weak anchor (see Fig. 2). However, 
this conformation was metastable, with the isolated peptide eventually collapsing to the surface in a manner sim-
ilar to the native one, only in this case the peptide’s N-terminus was strongly anchored to the silica surface and 
only the C-terminus was free to interact with the solvent environment.
www.nature.com/scientificreports/
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MD: Peptide Clusters Adsorbed on the Silica Surface. he diferent behaviour of the single GnRH-I 
and single cys-GnRH-I adsorption to the silica surface suggests that the peptides might adopt diferent confor-
mations in a crowded environment. Experimentally we load the SiNPs with many, rather than just individual, 
peptides and so we explored this in our simulations. To do this, we created islands of peptides at the surface, and 
ran the trajectories to explore the stability of the islands and whether the peptide conformation adapts to the 
presence of other peptides.
In the case of the native GnRH-I, we began with an island of 9 peptides on the surface. Each peptide was given 
the conformation shown in Fig. 2a, and the peptides were close-packed into a square array on the model silica 
surface. During the ensuing trajectory, some of the peptides at the edge of the island difused away to lower the 
surface density, as can be seen in Fig. 3, which shows the structure ater 50 ns. his spreading of the peptide island 
allowed greater access to the surface for the screening Na+ counter ions. Since GnRH-I is neutral, the surface 
charge density is not compensated by the adsorbed peptide, so the energy of the system is lowered by the separa-
tion of the peptides even though this reduces the van der Waals interactions between the peptides. A denser ilm 
of neutral peptides would impede the close approach of the counter ions to the surface, and so is energetically 
less favourable. As a consequence of this electrostatic driving force to keep the peptides separated, the way that 
the peptides present to the solution remains largely unchanged from the isolated peptide described above, with 
the N and C termini only loosely bound to the surface and available for interactions with the environment above 
the surface.
For the cys-GnRH-I island, we began with a close-packed array of 9 peptides with the elongated conformation 
taken from the isolated peptide adsorption simulations (see Fig. 2b). As shown in Fig. 3, this island tended to be 
more stable in the subsequent 50 ns trajectory. Here it is apparent that one of the peptides has difused away from 
the main cluster, but the remainder have stayed in a coherent island. his coniguration is favoured by the electro-
statics, since the charged N-terminus of the peptides balances the negative charge of the silica surface, screening 
it from the counter ions, which are not required here for surface neutralisation. Also apparent in Fig. 3 is that the 
elongated conformation of the cys-GnRH-I peptides is stabilised within the island, whereas for the isolated pep-
tide it was only metastable. It suggests that cys-GnRH-I will tend to adsorb in dense monolayers at the surface of 
the SiNPs, preferentially presenting the C-terminus to solution and using the positive N-terminus as the binding 
Figure 1. Simulated GnRH-I structures in solution shown using the licorice representation of VMD38: (a) 
native GnRH-I with hairpin bend; (b) cys-GnRH-I with net positive charge. Positive side chains are blue, 
negative are red. he green arrows indicate the dipole moment of the peptide.
www.nature.com/scientificreports/
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site to the surface. his is in contrast to the sparser layer preferred by native GnRH-I, where both termini are 
presented to the solution by the adsorbed peptide.
MD: The cys-GnRH-I-BSA Conjugate. We simulated a cys-GnRH-I-BSA conjugate in bulk solution, 
with two cys-GnRH-I peptides conjugated (as per the EDC 1-ethyl-3-[3-dimethylaminopropyl] carbodiimide 
reaction) to a BSA monomer. he peptides were conjugated to BSA via either the C- or N-terminus respec-
tively. Figure 4 clearly shows that one peptide (red, ‘Pep2’, conjugated using its C-terminus) remains in a very 
stable position attached to the BSA structure, whereas the other bound peptide (blue, ‘Pep1’, conjugated using 
the cysteine-tagged N-terminus) extends out from the BSA and interacts more freely with the surrounding envi-
ronment. his agrees with an earlier observation that conjugation through the N-terminus to a carrier protein is 
more efective in producing vaccination than through the C-terminus33.
he result from the MD simulation is encouraging; it suggests that cys-GnRH-I peptides conjugated to BSA 
can be free to interact with the surrounding environment. In a 1:1 weight ratio of BSA to peptide, there would be 
on average 20 peptides free to conjugate to each BSA monomer. herefore, it appears that there would be various 
points on the peptide-BSA conjugate that would expose GnRH-I epitopes to solution, presenting them for inter-
action with the immune system. As we will see below, this correlates well with speciic antibody results.
While further simulations should be carried out in order to investigate in detail how a greater number of pep-
tides bound to BSA would present themselves to solution, the results presented here support the interpretation 
that peptide-BSA conjugation creates useful systems for immunological response. Furthermore, while we do 
not explicitly simulate the adsorption of the peptide-decorated BSA to the SiNP, previous work24 shows that the 
BSA adsorbs in a speciic way while retaining its structure, so that the BSA-nanoparticle systems will retain the 
exposure of the peptides to solution.
ǣƤǤ We performed a series of immu-
nisation studies using the various treatments to the diferent groups given in Table 1; each dose delivered 50 µg 
of peptide, and each group comprised 5 animals following previous protocols8. We assessed the GnRH-speciic 
antibody and testosterone levels ater 13 weeks following fortnightly doses in each treatment group. In this way 
we aim to understand which treatments are most efective, and to then correlate the eicacy with the insight into 
the epitope presentation provided by the MD results shown above. We ind that all treatments have some immu-
nological impact, demonstrating that the various conjugates remain suiciently intact in vivo.
Figure 5 shows the inal GnRH-speciic IgG response in week 13 for all the groups. Student’s t-test between 
the treatment groups and the control are used to create the p-values, as routinely done in immunology studies; 
Figure 2. Simulated GnRH-I adsorption to the model silica surface: (a) isolated native GnRH-I collapsed to 
surface, binding through Arg; (b) cys-GnRH-I in a metastable upright position, bound at the N-terminus. he 
peptide is displayed as ‘licorice’ in VMD38, with sulphur yellow, oxygen red and hydrogen white, and the green 
arrow indicate the peptide dipole moments. he silica surface comprises red oxygen and yellow silicon ions. he 
water and counter ions are not shown for clarity.
www.nature.com/scientificreports/
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Figure 3. Clustering of GnRH-I at the silica surface: (a) native plan view; (b) native side-view; (c) cys-GnRH-I 
plan view; (d) cys-GnRH-I side view. he peptides are displayed using VMD ‘licorice’, with each peptide given a 
diferent colour for ease of identiication. he water is not shown for clarity.
Figure 4. he simulated cys-GnRH-I-BSA conjugate. he dark blue peptide (Pep1) is attached to the BSA via its 
cysteine residue, and is exposed to solution, whereas the red peptide (Pep2) is attached through its C-terminus 
glycine and is collapsed onto the BSA surface. he BSA is displayed as a ‘cartoon’ in VMD38 and the peptides as 
‘licorice’. he water is not shown for clarity.
www.nature.com/scientificreports/
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p-values below 0.001 show a signiicant increase in antibodies for all the treatments except Group II (Native 
GnRH-I, SiNP).
he inal antibody response for Group VII, the treatment using the BSA-cys-GnRH-I conjugate with SiNP, was 
much higher (A450 ~2.6 ± 0.3) than any other group, while the Group V antibody level for the BSA-cys-GnRH-I 
conjugate without the SiNP adjuvant was much reduced (A450 ~0.9 ± 0.4). hese antibody titres are similar to 
those induced in female mice, using a diferent carrier protein and lipid nanoparticle delivery system8.
he treatment groups using the native GnRH-I conjugated to BSA provided a similar response, with the SiNP 
adjuvants producing higher antibody responses (A450 ~2.1 ± 0.5 for Group VI with SiNP versus 1.5 ± 0.6 for 
Group IV without).
he antibody responses without the use of the carrier BSA protein were all lower still. Group III (cys peptide 
with SiNP) produced signiicant (p < 0.001) results, however the antibody response (A450 ~0.3 ± 0.2) was almost 
an order of magnitude lower than that of Group VII (cys peptide conjugated to BSA with SiNP). Similarly, Group 
II (native peptide with SiNP) showed an even lower antibody response, close to baseline, with only marginal sta-
tistical signiicant diference (p < 0.025) in comparison to the control Group I.
hese results indicate that the best immunological response is elicited by peptides conjugated to BSA adsorbed 
onto the SiNPs. he MD simulation results above provide a molecular-scale picture for this, since they show that 
the conjugates present epitopes to the solution more efectively than when the peptides are directly adsorbed to 
the SiNPs. he efectiveness of the BSA conjugates is improved when they are adsorbed to the SiNPs, which there-
fore act as adjuvants for this vaccine.
In Fig. 6, the results for the testosterone levels in study week 13 are shown. All treatments containing the native 
peptide (Groups II, IV and VI) produced a reduction in testosterone. Surprisingly, and in contrast to the antibody 
results, the Group II treatment with the native GnRH-I peptide directly adsorbed to the SiNP surface showed 
the greatest efect in reducing the average testosterone level, with a decrease of ~9.5 ng/ml (>95%, p < 0.001) 
from that of the control group. In stark contrast, the efects of Group III using cys-GnRH-I adsorbed to SiNPs 
showed no reduction in the average testosterone levels (p < 0.9). his pattern of behaviour is reproduced with the 
peptides conjugated to BSA; Groups IV and VI using BSA-native GnRH-I efectively reduced testosterone levels 
(p < 0.001), while Groups V and VII using BSA-cys-GnRH-I only did so to a much lesser extent (p < 0.6 and 
p < 0.75 respectively).
Group Treatment Delivery System
I Untreated control N/A
II Native GnRH-I SiNP
III Cys-GnRH-I SiNP
IV BSA-native GnRH-I None
V BSA-cys-GnRH-I None
VI BSA-native GnRH-I SiNP
VII BSA-cys-GnRH-I SiNP
Table 1. Immunisation treatment groups.
Figure 5. GnRH-speciic IgG antibody levels at 13 weeks measured by the absorbance at 450 nm against a 
standard curve supplied in the testosterone kit. he data are displayed as a box-plot which shows the median, 
2nd and 3rd quartile as the horizontal lines of the boxes, the mean as a symbol in the box, and whiskers showing 
the 9th and 91st percentiles. Outliers are also shown. ***p < 0.001; *p < 0.025 indicates responses signiicantly 
higher than the control.
www.nature.com/scientificreports/
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In summary, the Group II results appear to be antibody-independent, while the Groups IV, VI and VII are 
antibody-dependent. he results for Group V indicate that although an antibody response is invoked, it is not 
high enough to reduce testosterone levels to signiicant levels compared with the untreated controls.
hese results indicate hormonal response is sensitive to the GnRH-I sequence. he MD simulations above 
show that the native GnRH-I adsorbs to the silica using Arg8, and that the peptide N and C termini are available 
and exposed to the environment, while still retaining the hairpin loop secondary structure. However, the simu-
lations show that the cys-GnRH-I is bound to the silica surface via its N-terminal residue, which also results in 
some straightening of its hairpin loop structure. Consequently, the bound native residue is much more able to 
interact with the GnRH receptor, where terminal residue interactions are key34. Additionally, the cys-peptide has 
one of its terminal residues substituted (glutamic acid for cysteine) so cannot interact with the GnRH receptor as 
efectively. his also suggests the possibility that the antibodies produced with the cys-GnRH-I have low avidity 
due to the sequence modiication, although previous work35 suggests otherwise, and the lack of testosterone 
knock-down in Group III (Fig. 6) is due to inadequate antibody production (Fig. 5).
Hence, since the native peptide interacts efectively with the GnRH receptor, when it is conjugated to BSA or 
adsorbed to SiNPs, it may block the receptor. his would prevent free GnRH peptides interacting with the recep-
tor, consequently halting the production of testosterone. his would then account for the results obtained here, 
with the BSA-cys peptide conjugate systems having reduced impact due to the sequence modiication.
Immunological Study: Efect on spermatogenesis. At post-mortem, the testes were dissected and examined for the 
density of spermatozoa, spermatids, germinal epityhelium and quantity of sperm tails in the tubules to quantify 
the level of spermatogenesis. he scoring system used is deined in Table 2.
Complete azospermia was not seen in any of the testicular sections. However, there was arrest of spermato-
genesis in the convoluted seminiferous tubules at score level 5 as shown in Table 3. he highest rate of suppression 
was seen in case of SiNP-BSA-cys-GnRH-I treated animals (Group VII). Testicular spermatogenesis was mostly 
suppressed at score level 5 and the lowest in Groups I (untreated control) and III (SiNP-cysGnRH-I).
he clearest indication of eicacy was obtained by examining the percentage number of views attaining a 
score of 3 or less in a particular treatment group. Groups I and III only showed 2% of views with these scores. In 
Figure 6. Testosterone levels in serum in study week 13. he data are displayed as a box-plot which shows the 
median, 2nd and 3rd quartile as the horizontal lines of the boxes, the mean as a symbol in the box, and whiskers 
showing the 9th and 91st percentiles. Outliers are also shown. *P < 0.9; **P < 0.6; ***P < 0.001.
Scores Criteria
6 Complete spermatogenesis; characterised by regularly thickened germinal epithelium and a visible lumen; red sperm tail or blue sperm head coverage >50–80% in the lumen.
5 hickened germinal epithelium with a visible lumen, <50% lumen coverage with dull colored sperm tail
4 Disorganised germinal epithelium, marked sloughing of germ cells and obliteration of the lumen. Presence of degenerating sperm tails in the lumen with 10–15 spermatozoa/spermatids present/tubular sections
3 Few spermatozoa (<5–10) and/or spermatids (<10) present in the tubules. he germinal epithelium is scanty
2 No spermatozoa but few spermatids (<5–10) are present
1 No spermatozoa/spermatids but presence of several or many layers of spermatocytes
Table 2. Modiied criteria of testicular score count used to quantify level of suppressed spermatogenesis in mice 
testes42.
www.nature.com/scientificreports/
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comparison Groups IV and VI showed 4%, Group II 6%, and Groups V and VII 8%, with only Group VII showing 
a score of 1.
hese results indicate that the Group VII treatment was the most efective at arresting spermatogenesis. his 
is understandable in light of the efective antibody production alongside the testosterone reduction in this group. 
However, all treatments had some impact on the spermatogenesis, the only exception being Group III; Figs 5 and 
6 show that Group III is inefective in both producing antibody and reducing testosterone.
Discussion and Conclusions
In this study we have explored the use of spherical, non-porous 200 nm Stöber SiNPs as adjuvants for self-peptide 
vaccines. he experimental work has been supported and enhanced by biomolecular simulations that provide 
molecular-scale understanding of the vaccine systems, allowing the results to be interpreted with a physical 
insight that is otherwise unattainable.
It was found that immunisation against the native GnRH-I peptide adsorbed to SiNPs generated a poor 
immune response. his is perhaps due to the collapsed nature of the native peptide on the silica surface revealed 
by the simulations, thus resulting in the peptide being unavailable to interact with antigen presenting cells in 
vivo and therefore limiting the speciic immune response. In contrast, the cys-GnRH-I adsorbed onto the SiNPs 
elicits a speciic antibody response. Our simulations show that this peptide interacts with the silica surface via 
the N-terminal residue (cysteine) and ‘stands’ in a crowded peptide layer; therefore it is free to interact with the 
environment. If the peptide can interact with antigen presenting cells, it explains the generation of a speciic 
antibody response.
Conjugation of either the native GnRH-I or cys-GnRH-I to BSA results in an improved antibody response. 
In these formulations, the peptides are more likely to be exposed to the surrounding environment in vivo, as is 
apparent from our simulations. It should also be noted that the addition of SiNPs to these formulations enhances 
the speciic antibody response, so that the SiNP is an efective adjuvant for this vaccine.
he antibody efects of immunisation against these peptides appear to be in stark contrast to the hormonal 
efects. Mice treated with formulations including the native peptide all exhibited a marked decrease in testoster-
one production. Again we understand this efect in light of the simulation results. Since the terminal residues play 
a key role in the peptide interactions with the GnRH receptor, it is clearly favourable to retain the native sequence 
at the termini. Furthermore, systems that leave the termini free to interact with the external environment will be 
the most efective in blocking the receptors, and the simulations show that the native GnRH-I SiNP formulation 
fulils this requirement.
Arrest of spermatogenesis in the treatment groups correlates with the production of antibody or reduction in 
testosterone. Group VII, the treatment with cys-GnRH-I conjugated to BSA and adsorbed to the SiNP, was the 
most efective, whilst Group III with cys-GnRH-I directly adsorbed to SiNP was inefective.
It is therefore apparent that we can, with some success, interpret and understand the immunological responses 
to the vaccine systems by employing suitable molecular simulations. In order to successfully design and formu-
late peptide-based vaccines, the interactions between antigen and adjuvant have to be fully understood in order 
to produce an efective and stable product. he use of MD simulations allows these interactions to be studied in 
detail; we therefore believe that this combined modelling and experimental approach can facilitate the develop-
ment of new vaccines while greatly reducing the experimental load and costs, as well as providing a predictive tool 
that can lower the numbers of animals used in pre-clinical investigations of peptide vaccines.
Materials and Methods
Molecular Dynamics Simulations. Our computational simulations follow the methodology outlined in 
our previous work29. We used NAMD2.836 with the CHARMM27 force-ield and the TIP3P water model. We 
employed periodic boundary conditions, the Particle Mesh Ewald for the electrostatic interactions37 and a cut-of 
of 12 Å for short-range forces. Analyses of the trajectories were performed using VMD38.
he model silica surface was created from a {111} oriented slab of alpha-crystabolite terminated to create a 
dipole moment from the positive Si-rich surface to the O-rich one; the latter presents siloxide groups to the water 
above it, modelling the surface chemistry observed experimentally5. Furthermore, the use of periodic boundary 
conditions with such a slab creates an electric ield above the surface, again in line with experimental observations 
for Stöber SiNPs. his electric ield is screened by the addition of NaCl ions to the water; here we use a silica slab 
Treatment groups
Number of views at a particular 
score
6 5 4 3 2 1
I Control 21 19 9 1 — —
II SiNP-GnRH-I 18 22 7 2 1 —
III SiNP-Cys-GnRH-I 19 22 8 1 — —
IV BSA-GnRH-I 16 27 5 1 1 —
V BSA-Cys-GnRH-I 16 23 7 3 1 —
VI SiNP-BSA-GnRH-I 18 25 5 2 — —
VII SiNP-BSA-Cys-GnRH-I 15 22 9 2 1 1
Table 3. Testicular score counts using the criteria of Table 2.
www.nature.com/scientificreports/
9SCIENTIFIC REPORTS |         (2018) 8:17115 ȁǣ ? ?Ǥ ? ? ? ?Ȁ ? ? ? ? ?Ǧ ? ? ?Ǧ ? ? ? ? ?Ǧ ?
of dimensions 86 Å × 80 Å × 13 Å with 88 Na+ ions to screen the electric ield above the siloxide-rich surface, and 
88 Cl− ions to screen the positively charged Si-rich surface on the opposite side of the slab.
he native GnRH-I structure used was 1YY1.pdb39 and the cys-GnRH-I peptide was a modiied version of 
1YY1.pdb where the N-terminal glutamic acid residue was changed to a cysteine residue. he residue protonation 
was taken to be that at pH 7. he adsorption simulations were prepared with one peptide 20 Å above the target 
siloxide-rich surface, plus a distribution of the Na+ and Cl− ions, and the system was solvated in a water box 
that extended at least 15 Å away from any protein atom. he resulting systems contained ~80,000 atoms. Each 
simulation was preceded with an equilibration and minimisation period, with a production trajectory of 50 ns 
using a time-step of 1.0 fs. To reduce the computational time all bonds and angles in the water molecules were 
constrained.
he BSA-peptide system was prepared by adding the cys-GnRH-I at suitable surface sites on the BSA. We 
mimicked the covalent bonding of the peptide N-terminus to Phe308, and the C-terminus to Leu115. he MD 
trajectory for the solvated BSA-peptide system, containing ~180,000 atoms, was simulated for a duration of 50 ns 
at a constant temperature of 27 °C.
Materials Preparation. SiNPs were prepared using the Stöber synthesis method40. Tetraethylorthosilicate 
(TEOS, 99%, Aldrich Chemical Co.), ethanol (EtOH, 99.9%, Fisher Scientiic) and ammonium hydroxide (28.0–
30.0%, Sigma-Aldrich) were used as initial reactants for this synthesis. A peristaltic pump was used to control the 
addition rate of the TEOS/EtOH mixture.
he resulting nanoparticulate solution was centrifuged 3 times at 8,000 RPM and re-dispersed. It was stored 
in a 1:1 water/ethanol solution with a concentration of 0.2 g/mL silica. Figure 7 shows a scanning electron micro-
scope (SEM) image of the SiNPs manufactured in this study; a small sample of the suspension was dried on a 
support for this image. It shows that the nanoparticles are approximately spherical with a diameter ~200 nm with 
close homogeneity. Dynamic Light Scattering (DLS) measurements (not shown) conirm this, inding a mean 
diameter of 193 nm at pH 8.7 (polydispersity index, PDI, of 0.079) to 199 nm at pH 4.0 (PDI of 0.090).
Native GnRH-I (EHWSYGLRPG, 90% purity, synthesised by Genosphere Biotech, France) and a N-terminal 
modiied GnRH-I peptide, cys-GnRH-I (CHWSYGLRPG, 90% purity, synthesised by Immune Systems Ltd, UK), 
were used in this study. BSA and ovalbumin were purchased from Sigma-Aldrich Company Ltd, UK.
he immunogens consisted of either free peptides or peptide bound to BSA. Where the peptide was conju-
gated to BSA, each peptide was conjugated in a 1:1 weight ratio using the 1-ethyl-3-[3-dimethylaminopropyl] 
carbodiimide (EDC) reaction (Sigma-Aldrich Company Ltd, UK) and separated using 30 K Merck Millipore 
iltration tubes. he GnRH-I peptides (native and cys-GnRH-I) bound to ovalbumin were used as enzyme-linked 
immunosorbent assay (ELISA) plate coating antigens and were prepared via the same EDC reaction following 
Oonk et al.41.
Immunisation. All animal experiments were conducted in accordance to UK Home Oice Legislation and 
have been approved by the University of Strathclyde Ethical Review Committee. We used 5 animals in each 
treatment group and no repeats, in line with the Home Oice project licence guidelines to minimise the use of 
animals. In-house bred male BALB/c mice, aged 8 weeks at the start of the study, were kept in a controlled envi-
ronment: room temperature 22 °C; 50–70% humidity; summertime light cycle of 14 hours light per day; 5 ani-
mals per cage; one cage per treatment group. All mice were ear coded; food and water were supplied ad libitum. 
Subcutaneous injections were administered fortnightly; the mice were sacriiced ater 13 weeks and bloods taken. 
he immunisation treatment groups are provided in Table 1.
he Group II treatment was formulated by mixing 100 µL SiNPs (0.2 g/ml) and 900 µL deionised water. Native 
GnRH-I (1.0 mg) was dissolved in 1 mL deionised water and added to this solution. he resulting mixture was 
Figure 7. Scanning electron microscope image of the silica nanoparticles manufactured in this study. he scale 
bar is 1000 nm.
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stirred at room temperature for 1 h and then frozen at −20 °C until further use. he Group III treatment followed 
the same procedure, using cys-GnRH-I.
he treatment for Group IV was prepared by dissolving native GnRH-I and BSA in deionised water in equal 
weights (the inal sample containing 2.5 mg peptide). he BSA and peptides were then conjugated using the EDC 
reaction: the native GnRH-I was mixed with the BSA solution and stirred using a magnetic stirrer for 30 min 
at room temperature. EDC (50 mg) was dissolved in 1 mL deionised water. his was then added slowly to the 
protein/peptide mixture and stirred for 6 h. In order to remove excess EDC, the mixture was iltered using 30 K 
Merck Millipore ilters at 3500 RPM for 15 min. he resulting solution was then frozen at −20 °C until further 
use. Group V’s treatment was prepared in the same way using cys-GnRH-I. Group VI and VII used the conju-
gated native and cys-GnRH-I solutions respectively, mixing them with 100 µL SiNPs (0.2 g/ml) +900 µL deionised 
water and then frozen at −20 °C to await further use.
In all immunisation treatment groups, each mouse was fortnightly administered a subcutaneous dose of 
0.1 mL formulation, containing the equivalent of 50 µg of peptide per dose. Ater 13 weeks, 7 days ater the inal 
administration, blood was collected via cardiac puncture. Each blood sample was centrifuged at 1000 g for 20 min. 
he serum was then collected in fresh microfuge tubes and frozen at −20 °C until analysed by ELISA.

ǦƤǤ All wash steps were carried 
out three times with phosphate bufered saline (PBS), pH 7.4, containing 0.01% (v/v) Tween 20 (PBS-Tween) and 
incubations carried out for 1 h at 37 °C unless otherwise stated. A tissue culture grade 96-well plate was coated 
with the corresponding GnRH-I peptide-ovalbumin conjugate and the ELISA carried out as described by Gebril 
et al. (2014)8. he absorbance at 450 nm of each plate was read on a SpectraMax M5 plate reader (Molecular 
Devices, USA).
Serum testosterone levels were measured using a testosterone ELISA kit (Alpha Diagnostic International 
USA) according to the manufacturer’s instructions. All mouse sera samples were assayed in duplicate and low 
and high testosterone control samples were included in all runs.
ơǤ At post-mortem, the testes were dissected and preserved 
in formalin, and tissues were sectioned42. A total of ity tubular cross sections per testes was examined by light 
microscopy for the densities of spermatozoa, spermatids, germinal epithelium and quality of sperm tails in the 
tubules to quantify the level of spermatogenesis. he criteria in Table 2 was used to provide a scoring system.
Data Availability
Supplementary Materials: run iles for the MD simulations reported here are available at https://doi.org/10.15129/70d-
c12db-5f73-4603-8242-80202c99f7be.
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